AM2: APRAMYCIN
AM2 is a Ligand Of Interest in 6MN4 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6MN4_AM2_A_301 | 21% | 24% | 0.236 | 0.845 | 1.67 | 1.42 | 8 | 7 | 0 | 0 | 100% | 0.96 |
| 6MN4_AM2_B_301 | 20% | 23% | 0.242 | 0.844 | 1.74 | 1.45 | 6 | 10 | 1 | 0 | 100% | 0.98 |
| 6MN4_AM2_C_301 | 6% | 31% | 0.274 | 0.713 | 1.64 | 1.1 | 7 | 2 | 3 | 0 | 100% | 0.97 |
| 6MN4_AM2_E_301 | 5% | 25% | 0.315 | 0.734 | 1.69 | 1.35 | 8 | 5 | 0 | 0 | 100% | 0.9 |
| 6MN4_AM2_D_301 | 4% | 27% | 0.315 | 0.696 | 1.7 | 1.27 | 6 | 5 | 1 | 0 | 100% | 0.9 |
| 6MN4_AM2_F_301 | 0% | 25% | 0.518 | 0.306 | 1.68 | 1.4 | 7 | 6 | 1 | 0 | 100% | 0.8 |
| 4K31_AM2_C_101 | 86% | 65% | 0.091 | 0.958 | 0.41 | 0.92 | - | 2 | 0 | 0 | 100% | 1 |
| 2OE5_AM2_B_101 | 81% | 32% | 0.088 | 0.94 | 1.57 | 1.12 | 11 | 4 | 0 | 0 | 100% | 1 |
| 7JM2_AM2_B_301 | 73% | 35% | 0.095 | 0.921 | 1.54 | 1.03 | 6 | 3 | 0 | 0 | 100% | 1 |
| 2G5K_AM2_A_102 | 53% | 31% | 0.166 | 0.927 | 1.71 | 1.04 | 11 | 4 | 0 | 0 | 100% | 1 |
| 2OE8_AM2_B_101 | 47% | 29% | 0.14 | 0.88 | 1.91 | 0.97 | 15 | 2 | 0 | 0 | 100% | 1 |
